Allergan (Acquired 2015) is Surgical Devices in United States that focus on commercializing pharmaceuticals business. Founded in 1948. They cover business area such as developer, pharmaceutical product, biologic, medical device, the-counter, its product, BOTOX®, onabotulinumtoxina, RESTASIS®, cyclosporine ophthalmic emulsion, LUMIGAN®, (bimatoprost ophthalmic solution, dermal filler.
1948
( 76 years old in 2024 )
Commercializing Pharmaceuticals
-
2525 Dupont Drive
Irvine, CA 92612
United States
Private
developerpharmaceutical productbiologicmedical devicethe-counterits productBOTOX®onabotulinumtoxinaRESTASIS®cyclosporine ophthalmic emulsionLUMIGAN®(bimatoprost ophthalmic solutiondermal filler
* We use standard office opening hours in near Allergan (Acquired 2015)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Allergan (Acquired 2015) is Surgical Devices business from United States that founded in 1948 (76 years old in 2024), Allergan (Acquired 2015) business is focusing on Commercializing Pharmaceuticals.
Allergan (Acquired 2015) headquarter office and corporate office address is located in 2525 Dupont Drive Irvine, CA 92612 United States.
Allergan (Acquired 2015) was founded in United States.
In 2024, Allergan (Acquired 2015) is currently focus on commercializing pharmaceuticals sector.
Above is snippet of Google Trends for "commercializing pharmaceuticals" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Allergan (Acquired 2015), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
